Marko Kumric,Tina Ticinovic Kurir,Josko Bozic et al.
Marko Kumric et al.
Acutely decompensated heart failure is one of the leading causes of hospitalisation worldwide, with a significant majority of these cases attributed to congestion. Although congestion is commonly mistaken for volume overload, evidence sugge...
Transcatheter Aortic Valve Replacement is Ready for Most Low-risk Patients: A Systematic Review of the Literature [0.03%]
经导管主动脉瓣植入术已准备好应用于大部分低危患者-文献系统回顾
Ahmad Jabri,Anas Alameh,Gennaro Giustino et al.
Ahmad Jabri et al.
Transcatheter aortic valve replacement (TAVR) has undergone rapid expansion, emerging as a viable therapeutic option for low-risk patients in lieu of surgical aortic valve replacement. This paper aims to provide a review of the scientific e...
Ritu Thamman,Naeimeh Hosseini,Marie-Luise Dikou et al.
Ritu Thamman et al.
This paper delves into the significance of imaging in the diagnosis, aetiology and therapeutic guidance of heart failure, aiming to facilitate early referral and improve patient outcomes. Imaging plays a crucial role not only in assessing l...
Haemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitor Treatment in Chronic Heart Failure Patients [0.03%]
钠-葡萄糖共转运蛋白2抑制剂治疗对慢性心力衰竭患者血流动力学的影响
C Noah Nilsson,Mads Kristian Ersbøll,Finn Gustafsson
C Noah Nilsson
Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are now recommended in the current European Society of Cardiology/American College of Cardiology guidelines for the treatment of heart failure (HF) across the spectrum of left ventricular ...
Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiac Function, Exercise Capacity and Quality of Life [0.03%]
胰高血糖素样肽1受体激动剂对心脏功能、运动能力和生活质量的影响
Anastasia Shchendrygina,Amina Rakisheva,Ilya Giverts et al.
Anastasia Shchendrygina et al.
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are emerging glucose-lowering agents primarily used in managing diabetes and obesity. Recently, GLP-1 RAs have garnered attention for their cardiovascular benefits beyond glycaemic con...
Nikhilesh Srinivasan,Nagesh Gullapalli,Kevin S Shah
Nikhilesh Srinivasan
Heart failure (HF) remains a progressive syndrome with high morbidity and mortality, and accounts for many hospitalisations globally with a downstream impact of increasing healthcare costs. South Asian individuals account for most of the gl...
William Herrik Nielsen,Finn Gustafsson
William Herrik Nielsen
Iron deficiency is a common and independent predictor of adverse outcomes in patients with heart failure. The implications of iron deficiency in patients implanted with a left ventricular assist device (LVAD) are less established. This revi...
Evaluating Biomarkers as Tools for Early Detection and Prognosis of Heart Failure: A Comprehensive Review [0.03%]
心力衰竭早期诊断和预后生物标志物评估：全面回顾
Moza A Alzaabi,Amin Abdelsalam,Majid Alhammadi et al.
Moza A Alzaabi et al.
There is a high prevalence of heart failure (HF) worldwide, which has significant consequences for healthcare costs, patient death and quality of life. Therefore, there has been much focus on finding and using biomarkers for early diagnosis...
Aniket S Rali,Lena Tran,Malcolm Dix et al.
Aniket S Rali et al.
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment [0.03%]
射血分数保留的心力衰竭的治疗和管理：新的治疗方法展望
Giulio Balestrieri,Raul Limonta,Enrico Ponti et al.
Giulio Balestrieri et al.
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterised by the presence of diastolic dysfunction and elevated left ventricular filling pressure, in the setting of a left ventricular ejection fraction of a...